- Home
- VIVS vs SPHL Comparison
VIVS vs SPHL Comparison
Compare VIVS & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- SPHL
- Stock Information
- Founded
- VIVS 2007
- SPHL 2002
- Country
- VIVS United States
- SPHL Singapore
- Employees
- VIVS N/A
- SPHL N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- SPHL Homebuilding
- Sector
- VIVS Health Care
- SPHL Consumer Discretionary
- Exchange
- VIVS Nasdaq
- SPHL Nasdaq
- Market Cap
- VIVS 5.0M
- SPHL 6.0M
- IPO Year
- VIVS N/A
- SPHL 2024
- Fundamental
- Price
- VIVS $2.21
- SPHL $0.54
- Analyst Decision
- VIVS
- SPHL
- Analyst Count
- VIVS 0
- SPHL 0
- Target Price
- VIVS N/A
- SPHL N/A
- AVG Volume (30 Days)
- VIVS 70.9K
- SPHL 101.3K
- Earning Date
- VIVS 08-05-2025
- SPHL 02-21-2025
- Dividend Yield
- VIVS N/A
- SPHL N/A
- EPS Growth
- VIVS N/A
- SPHL N/A
- EPS
- VIVS N/A
- SPHL N/A
- Revenue
- VIVS $144,000.00
- SPHL $6,456,601.00
- Revenue This Year
- VIVS $42.38
- SPHL N/A
- Revenue Next Year
- VIVS $15.42
- SPHL N/A
- P/E Ratio
- VIVS N/A
- SPHL N/A
- Revenue Growth
- VIVS 32.11
- SPHL N/A
- 52 Week Low
- VIVS $1.41
- SPHL $0.35
- 52 Week High
- VIVS $21.96
- SPHL $7.80
- Technical
- Relative Strength Index (RSI)
- VIVS N/A
- SPHL N/A
- Support Level
- VIVS N/A
- SPHL N/A
- Resistance Level
- VIVS N/A
- SPHL N/A
- Average True Range (ATR)
- VIVS 0.00
- SPHL 0.00
- MACD
- VIVS 0.00
- SPHL 0.00
- Stochastic Oscillator
- VIVS 0.00
- SPHL 0.00
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.